This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1bh0

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1bh0.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1bh0.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1bh0| PDB=1bh0 | SCENE= }}
{{STRUCTURE_1bh0| PDB=1bh0 | SCENE= }}
-
'''STRUCTURE OF A GLUCAGON ANALOG'''
+
===STRUCTURE OF A GLUCAGON ANALOG===
-
==Overview==
+
<!--
-
We have designed and synthesized eight compounds 2-9 which incorporate various amino acid residues in positions 17, 18, and 21 of the glucagon molecule: 2, [Lys17]glucagon amide; 3, [Lys18]glucagon amide; 4, [Nle17,Lys18,Glu21]glucagon amide; 5, [Orn17,18, Glu21]glucagon amide; 6, [d-Arg17]glucagon; 7, [d-Arg18]glucagon; 8, [d-Phe17]glucagon; and 9, [d-Phe18]glucagon. Compared to glucagon (IC50 = 1.5 nM), analogues 2-9 were found to have binding affinity IC50 values (in nM) of 0.7, 4.1, 1.0, 2.0, 5.0, 25.0, 43.0, and 32.0, respectively. When these compounds were tested for their ability to stimulate adenylate cyclase (AC) activity, they were found to be full or partial agonists having maximum stimulation values of 100, 100, 100, 100, 87, 78, 94, and 100%, respectively. On the basis of the X-ray crystal structure of [Lys17,18,Glu21]glucagon amide reported here, the ability to form a salt bridge between Lys18 and Glu21 is probably key to their increased binding and second messenger activities. Among the eight analogues synthesized here, only analogue 4 preserves the ability to form a salt bridge between Lys18 and Glu21. However, since these modifications are minor they do not seem to change the amphiphilic character of the C-terminus, allowing these analogues to reach 78-100% stimulation in the adenylate cyclase assay. Biological data from analogues 6-9 supports the idea that position 18 of glucagon may influence binding only, while position 17 may influence both receptor recognition and transduction.
+
The line below this paragraph, {{ABSTRACT_PUBMED_9667960}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9667960 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9667960}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Trivedi, D.]]
[[Category: Trivedi, D.]]
[[Category: Synthetic hormone]]
[[Category: Synthetic hormone]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 11:30:00 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 19:08:59 2008''

Revision as of 16:09, 30 June 2008

Image:1bh0.png

Template:STRUCTURE 1bh0

STRUCTURE OF A GLUCAGON ANALOG

Template:ABSTRACT PUBMED 9667960

About this Structure

1BH0 is a Single protein structure. Full crystallographic information is available from OCA.

Reference

Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity., Sturm NS, Lin Y, Burley SK, Krstenansky JL, Ahn JM, Azizeh BY, Trivedi D, Hruby VJ, J Med Chem. 1998 Jul 16;41(15):2693-700. PMID:9667960

Page seeded by OCA on Mon Jun 30 19:08:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1bh0"
Personal tools